Results 101 to 110 of about 72,253 (289)

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri, Bruno Bergmans, Eric Freire‐Alvarez, Lucie Hopes, Drew S. Kern, Robert S. Kirsner, Giulia Lazzeri, Pedro Mendes‐Bastos, Noriko Nishikawa, Per Odin, Karolina Poplawska‐Domaszewicz, Rajesh Pahwa, Yuval Ramot, Klaus Seppi, Tobias Warnecke, Robert Wiggins, Megha B. Shah, Pavnit Kukreja, Bjoern Fritz, Koray Onuk, Stuart H. Isaacson   +20 more
wiley   +1 more source

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease

International Journal of COPD, 2010
Sonal Singh1, Yoon K Loke21Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; 2School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, EnglandBackground: The benefit harm profile of ...
Sonal Singh, Yoon K Loke
doaj  

Could Fractional Exhaled Nitric Oxide Test be Useful in Predicting Inhaled Corticosteroid Responsiveness in Chronic Cough? A Systematic Review [PDF]

, 2016
© 2016 Background Fractional exhaled nitric oxide (FENO) is a safe and convenient test for assessing T H 2 airway inflammation, which is potentially useful in the management of patients with chronic cough.
Chang, Yoon-Seok, Cho, Sang-Heon, Chung, Soo-Jie, Kang, Sung-Yoon, Kim, Byung-Keun, Kim, Ju-Young, Kim, Mi-Yeong, Lee, Byung-Jae, Lim, Kyung-Hwan, Moon, Sung-Do, Morice, Alyn H., Park, Heung-Woo, Sohn, Kyoung-Hee, Song, Woo-Jung, Won, Ha-Kyeong, Yang, Min-Suk   +15 more
core   +1 more source

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives—A Narrative Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz, Marina Farah, Laura Silveira‐Moriyama   +2 more
wiley   +1 more source

Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? – study protocol for a randomized controlled trial [NCT00120978]

BMC Pulmonary Medicine, 2006
Background Systemic inflammation is associated with various complications in chronic obstructive pulmonary disease including weight loss, cachexia, osteoporosis, cancer and cardiovascular diseases.
Ramesh Warren, Mainra Rajesh R, York Ernest, Wong Eric, FitzGerald Mark, Ford Gordon, Marciniuk Darcy D, Man SF Paul, Sin Don D, Melenka Lyle S, Wilde Eric, Cowie Robert L, Williams Dave, Rousseau Roxanne   +13 more
doaj   +1 more source

The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers. [PDF]

, 2003
Nanocrystal budesonide (nanobudesonide) is a suspension for nebulization in patients with steroid-responsive pulmonary diseases such as asthma. The pharmacokinetics and safety of the product were compared to those of Pulmicort Respules.
Beussink, Don, Fitzgerald, Nancy, Greenberg, Howard E., Kraft, Walter, Quiring, John N., Steiger, Barry, Waldman, Scott A.   +6 more
core   +3 more sources

Evidence‐based guideline for clinical practice in the diagnosis, treatment, management, and prevention of recurrent wheezing in infants and toddlers in China

Pediatric Investigation, EarlyView.
ABSTRACT Wheezing is a common respiratory symptom in infants and toddlers, and recurrent wheezing is a significant respiratory disorder affecting this age group. Given the multifactorial etiology of recurrent wheezing, clinical practice lacks standardized diagnostic and therapeutic protocols. Recent years have witnessed substantial progress in clinical
Committee of Pediatrics, China Medical Education Association, Cooperative Group of Asthma, the Subspecialty Group of Respiratory, the Society of Pediatrics, Chinese Medical Association, Pediatric Respiratory Work Committee, Society of Pulmonologists, Chinese Medical Doctor Association, Committee of Pediatrics, Chinese Research Hospital Association, Pediatric Professional Committee of the Chinese Non‐public Medical Institutions Association, Professional Committee of Children's Health and Pharmaceutical Research, China Association of Traditional Chinese Medicine, Children's Safe Medication Branch of China News of Drug Information Association, Pediatric Expert Committee of China Primary Health Care Foundation, China International Medical Foundation   +16 more
wiley   +1 more source

The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study

Therapeutic Advances in Respiratory Disease, 2009
Background: Several studies suggest that inhaled and oral corticosteroids repress systemic inflammation in chronic obstructive pulmonary disease (COPD). However, the cytokines that may respond to these medications are unclear.
S.F. Paul Man, Xuekui Zhang, Rupert Vessey, Terry Walker, Kwan Lee, Dan Park, Don D. Sin   +6 more
doaj   +1 more source

LINX®, a novel treatment for patients with refractory asthma complicated by gastroesophageal reflux disease: a case report. [PDF]

, 2016
BackgroundGastroesophageal reflux disease is one of the most common comorbidities in patients with asthma. Gastroesophageal reflux disease can be linked to difficult-to-control asthma.
Kenyon, Nicholas J, Kivler, Celeste, Louie, Samuel, Murin, Susan, Sriratanaviriyakul, Narin, Vidovszky, Tamas J, Yoneda, Ken Y   +6 more
core   +2 more sources

Anti‐Allergic Potential of Chamaecrista nomame and Its Compound Luteolin for Novel Asthma Therapy

Phytotherapy Research, EarlyView.
Chamaecrista nomame (CN) and its active compound luteolin attenuate allergic airway inflammation by inhibiting mast cell activation and suppressing NF‐κB/MAPK signaling, leading to reduced cytokine production and OVA‐specific IgE levels. ABSTRACT Asthma is a chronic inflammatory disease driven by dysregulated immune responses and mast cell activation ...
Tae Kyeom Kang, Myungsuk Kim, Tam Thi Le, Geon Park, Yuna Jung, Hyobin Jeong, Youngsang Yoo, Wook‐Bin Lee, Sang Hoon Jung   +8 more
wiley   +1 more source